🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Transitioning to Home or In-center Dialysis

Recruitingn/aAges 18 Years - anyAllCiusss de L'Est de l'Île de Montréal
NCT05989659 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

For people with advanced kidney disease, deciding which type of dialysis is best can be challenging. Studies have shown that quality of life is very important to patients. It is thought that the quality of life of people receiving their dialysis at home may be better than the one of people receiving dialysis in a hospital. However, how the start of dialysis changes the quality of life of people who choose home dialysis in comparison to people choosing dialysis in a hospital is still unknown. TRANSIT-CARE is a prospective mixed methods study following adult with advanced kidney disease who progress to dialysis and receive home or hospital-based dialysis. This study aims to examine the trajectory and change in patients' quality of life and their frailty status (health, mobility and function) before start of dialysis and up to 12-month after start. Differences between people doing home dia

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: 1. Adults followed in advanced CKD clinic, 2. estimated glomerular filtration rate (eGFR) \<12 mL/min/1.73m2 103, 3. Have chosen their dialysis modality, 4. Understand English or French. Exclusion Criteria: 1. Orientation toward conservative treatment, 2. Planned kidney transplantation \< 6 months, 3. Unable to provide consent due to severe cognitive or psychiatric disease, 4. Previous treatment with dialysis \> 3 months, 5. Life expectancy \< 6 months
💊

What it tests

  • Exposure: Home dialysis or facility-hemodialysis
📍

Where

1 site
Hôpital Maisonneuve-Rosemont
Montreal, Canada
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy